Johnson & Johnson develops first antidepressant nasal spray for actively suicidal people; here is how it works | The Times of India
![Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant | Health and Quality of Life Outcomes | Full Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant | Health and Quality of Life Outcomes | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-023-02113-1/MediaObjects/12955_2023_2113_Fig2_HTML.png)
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant | Health and Quality of Life Outcomes | Full
![Premium Photo | Pain reliever use of antidepressant male self treatment man with pills nasal spray cough cold and runny nose remedy coronavirus from china suffering from insomnia health and medicine hangover Premium Photo | Pain reliever use of antidepressant male self treatment man with pills nasal spray cough cold and runny nose remedy coronavirus from china suffering from insomnia health and medicine hangover](https://img.freepik.com/premium-photo/pain-reliever-use-antidepressant-male-self-treatment-man-with-pills-nasal-spray-cough-cold-runny-nose-remedy-coronavirus-from-china-suffering-from-insomnia-health-medicine-hangover_474717-137046.jpg?w=2000)
Premium Photo | Pain reliever use of antidepressant male self treatment man with pills nasal spray cough cold and runny nose remedy coronavirus from china suffering from insomnia health and medicine hangover
![SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression | Psychiatrist.com SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2021/11/JA18039_Table1REV-scaled.gif)
SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression | Psychiatrist.com
![SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News](https://hospitalprofessionalnews.ie/wp-content/uploads/2022/03/spravato-esketamine-spray-233x300-1.png)
SPRAVATO ®▽ (esketamine) nasal spray approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder - Hospital Professional News
![PDF] Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. | Semantic Scholar PDF] Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b1c53612cb067d6257056ffdc170aceffde907f6/4-Figure1-1.png)
PDF] Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. | Semantic Scholar
![suffering from insomnia. Health and medicine, hangover. use of antidepressant. male self treatment. Man with pills and nasal spray. cough cold and Stock Photo - Alamy suffering from insomnia. Health and medicine, hangover. use of antidepressant. male self treatment. Man with pills and nasal spray. cough cold and Stock Photo - Alamy](https://c8.alamy.com/comp/2GH6N8T/suffering-from-insomnia-health-and-medicine-hangover-use-of-antidepressant-male-self-treatment-man-with-pills-and-nasal-spray-cough-cold-and-2GH6N8T.jpg)
suffering from insomnia. Health and medicine, hangover. use of antidepressant. male self treatment. Man with pills and nasal spray. cough cold and Stock Photo - Alamy
![Ketamine antidepressant spray treatment not available for patients…because of cost? – Speaking of Research Ketamine antidepressant spray treatment not available for patients…because of cost? – Speaking of Research](https://speakingofresearch.files.wordpress.com/2020/02/ketamine-cost.jpg)
Ketamine antidepressant spray treatment not available for patients…because of cost? – Speaking of Research
![SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression | Psychiatrist.com SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression | Psychiatrist.com](https://www.psychiatrist.com/wp-content/uploads/2021/06/JA18039figure4.gif)
SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression | Psychiatrist.com
![Major Depressive Disorder with Suicidal Thoughts or Actions (MDSI) Data & Dosing | SPRAVATO® (esketamine) HCP Major Depressive Disorder with Suicidal Thoughts or Actions (MDSI) Data & Dosing | SPRAVATO® (esketamine) HCP](https://www.spravatohcp.com/sites/www.spravatohcp-v1.com/files/study-design-desktop.webp)
Major Depressive Disorder with Suicidal Thoughts or Actions (MDSI) Data & Dosing | SPRAVATO® (esketamine) HCP
![Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant | Health and Quality of Life Outcomes | Full Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant | Health and Quality of Life Outcomes | Full](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-023-02113-1/MediaObjects/12955_2023_2113_Fig3_HTML.png)
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant | Health and Quality of Life Outcomes | Full
![Study design and disposition of patients. a Standard antidepressant... | Download Scientific Diagram Study design and disposition of patients. a Standard antidepressant... | Download Scientific Diagram](https://www.researchgate.net/publication/344078075/figure/fig1/AS:991848956977153@1613486627316/Study-design-and-disposition-of-patients-a-Standard-antidepressant-treatment-was.png)